The Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and US Medical Innovations, LLC (USMI) are pleased to announce a ground-breaking achievement in surgical and robotic technology. The Canady Robotic AI Surgical System is the world’s first AI robotic system that delivers cold atmospheric plasma (CAP)...
Dante Genomics , a global leader in genomics and precision medicine, announced a strategic AI collaboration with Amazon Web Services (AWS) to bring generative AI to the clinical care of patients with genetic diseases.
Dante Genomics' early focus on whole-genome sequencing gives the company a natural competitive advantage in creating...
Seasoned Expert Joins to Drive Fractyl's Pioneering Mission Forward with its Revita® and Rejuva® Programs for Type 2 Diabetes and Obesity
Fractyl Health, a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes (T2D) and obesity, proudly announces the appointment of Dr. Timothy...
Deep Genomics, a leading AI drug development company focused on decoding biology to program life-changing medicines, announced that as part of its strategic plan to evolve into a forward-integrated biopharmaceutical company, Brian O’Callaghan has been appointed chief executive officer (CEO) and member of the board of directors. Mr. O’Callaghan,...
Logica, an offering from Charles River and Valo Health, will be used to discover first-in-class therapeutics against high value targets in the Related Sciences portfolio
Charles River Laboratories International, Inc. and Related Sciences, a data science-driven drug discovery firm, announced a multi-program collaboration agreement to apply Logica™ across several previously undrugged...
Generate:Biomedicines, a clinical-stage biotherapeutics company pioneering a machine-learning-powered generative biology platform, announced that it has raised $273 million in Series C financing. This financing round attracted many new investors including Amgen; NVentures, NVIDIA’s venture capital arm; MAPS Capital; and Pictet Alternative Advisors. Additionally, company founder, Flagship Pioneering, and every...
SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, has expanded its relationship with Laboratorio Curie, a leading laboratory located in the capital city of Paraguay. Laboratorio Curie is now live on the SOPHiA DDM™ Platform and will use the technology to deploy a new test that will...
Infleqtion, the world's quantum information company, announced that it had been awarded funding from Wellcome Leap's Quantum for Bio (Q4Bio) program with a team of renowned researchers and medical doctors at the University of Chicago (UChicago) and Massachusetts Institute of Technology (MIT). This collaborative effort aims to transform cancer care by harnessing the power...
BenevolentAI, a leader in the development of advanced AI that accelerates biopharma discovery, announces the appointment of Catherine Isted, ACMA, who will be joining the Company as Chief Financial Officer with immediate effect.
Catherine is an experienced strategic finance professional and chartered accountant with over 25 years within the life...
HumanFirst, a cloud-based software company accelerating patient-centered drug development through AI-powered insights, announced the launch of the industry's first-of-its-kind precision measures platform. HumanFirst's platform enables pharma and biotechs to reliably incorporate patient-centric measures and validated technologies into clinical research.
With life science organizations under pressure to increase R&D efficiency and...
